These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 1794967

  • 21. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
    Wooldridge TN, Grierson HL, Weisenburger DD, Armitage JO, Sanger WG, Collins MM, Pierson JL, Pauza ME, Fordyce R, Purtilo DT.
    Cancer Res; 1988 Nov 15; 48(22):6608-13. PubMed ID: 3052808
    [Abstract] [Full Text] [Related]

  • 22. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
    Czader M, Porwit A, Tani E, Ost A, Mazur J, Auer G.
    Mod Pathol; 1995 Jan 15; 8(1):51-8. PubMed ID: 7731942
    [Abstract] [Full Text] [Related]

  • 23. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
    ten Velde GP, Schutte B, Reijnders MM, Bosman FT, Blijham GH.
    Cytometry; 1989 Nov 15; 10(6):807-10. PubMed ID: 2582973
    [Abstract] [Full Text] [Related]

  • 24. DNA content of T-cell lymphomas. A flow-cytometric analysis.
    Egerter DA, Said JW, Epling S, Lee S.
    Am J Pathol; 1988 Feb 15; 130(2):326-34. PubMed ID: 3257649
    [Abstract] [Full Text] [Related]

  • 25. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S, Comino A, Fruttero A, Torchio P, Bouzari H, Taraglio S, Torchio B, Capussotti L.
    Cancer; 1996 Sep 15; 78(6):1195-202. PubMed ID: 8826940
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of the correlations of cell proliferation activity with lymphatic and vascular invasion and prognosis in gastric carcinoma].
    Wu YF, Xu HM, Chen JQ.
    Zhonghua Zhong Liu Za Zhi; 2005 Aug 15; 27(8):492-5. PubMed ID: 16188150
    [Abstract] [Full Text] [Related]

  • 27. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS, Flotte T, Hsu DW, Preffer F, Hedley-Whyte ET.
    Gen Diagn Pathol; 1996 Oct 15; 142(2):89-95. PubMed ID: 8950573
    [Abstract] [Full Text] [Related]

  • 28. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R, Wimberger P, Hillemanns P, Kapsner T, Caspari C, Hepp H.
    Gynecol Oncol; 2002 Jan 15; 84(1):21-31. PubMed ID: 11748971
    [Abstract] [Full Text] [Related]

  • 29. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
    Strang P, Stenkvist B, Bergström R, Stendahl U, Valdes del Campo M, Tribukait B.
    Anticancer Res; 1991 Jan 15; 11(2):783-8. PubMed ID: 2064334
    [Abstract] [Full Text] [Related]

  • 30. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.
    Yonemura Y, Ooyama S, Sugiyama K, Kamata T, De Aretxabala X, Kimura H, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I.
    Cancer Res; 1990 Feb 01; 50(3):509-14. PubMed ID: 2297693
    [Abstract] [Full Text] [Related]

  • 31. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
    Morita K, Hayashi Y, Nagao S, Watanabe Y.
    Gan To Kagaku Ryoho; 1995 Jun 01; 22 Suppl 2():164-7. PubMed ID: 7611782
    [Abstract] [Full Text] [Related]

  • 32. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
    Baldetorp B, Bendahl PO, Fernö M, Alanen K, Delle U, Falkmer U, Hansson-Aggesjö B, Höckenström T, Lindgren A, Mossberg L.
    Cytometry; 1995 Jun 15; 22(2):115-27. PubMed ID: 7587742
    [Abstract] [Full Text] [Related]

  • 33. [Evaluation of cell cycle in acute leukemias and non-Hodgkin's lymphomas in children].
    Pituch-Noworolska A, Gawlicka M.
    Acta Haematol Pol; 1993 Jun 15; 24(4):365-71. PubMed ID: 8303983
    [Abstract] [Full Text] [Related]

  • 34. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
    Trerè D, Ceccarelli C, Danova M, Derenzini M.
    Eur J Histochem; 1996 Jun 15; 40(1):17-26. PubMed ID: 8741096
    [Abstract] [Full Text] [Related]

  • 35. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV, Jin JK, Dougherty S, Flanigan RC, Graham S, Pyle JM.
    Cytometry; 1995 Sep 01; 21(1):30-9. PubMed ID: 8529468
    [Abstract] [Full Text] [Related]

  • 36. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM, Chiou CR, Ko JY, Sheen TS, Hong RL, Ting LL.
    Cancer Detect Prev; 2000 Sep 01; 24(2):119-26. PubMed ID: 10917131
    [Abstract] [Full Text] [Related]

  • 37. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
    Wu HM.
    J Tongji Med Univ; 1992 Sep 01; 12(2):65-70. PubMed ID: 1433420
    [Abstract] [Full Text] [Related]

  • 38. S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.
    Witzig TE, Habermann TM, Kurtin PJ, Schroeder G, Stenson MJ, Greipp PR.
    Cancer; 1995 Sep 15; 76(6):1059-64. PubMed ID: 8625208
    [Abstract] [Full Text] [Related]

  • 39. Determination of G1-S-G2 phase fraction ratios of tumour subpopulations from DNA histograms.
    Molnár B, Szentirmay Z, Bodó M, Sugár J, Fehér J, Pick R, Tusnady Z.
    Acta Morphol Hung; 1992 Sep 15; 40(1-4):125-35. PubMed ID: 1365759
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.